PSMA PET Staging is Advised for All High-Risk Patients With Localized Prostate Cancer

被引：0
|
作者：
Murphy, Declan G. [1 ,2 ]
Emmett, Louise [3 ]
机构：
[1] Peter MacCallum Canc Ctr, Div Canc Surg, Melbourne, Vic, Australia
[2] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic, Australia
[3] St Vincents Hosp, Dept Theranost & Nucl Med, Sydney, NSW, Australia
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 120卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2024.06.031
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3
引用
收藏
页码：642 / 645
页数：4
相关论文
共 50 条
  • [31] Multimodality Approach with 68Ga-PSMA-11 PET/CT in Staging High-risk Prostate Cancer Patients Candidate to Radical Prostatectomy
    Rovera, G.
    Grimaldi, S.
    Oderda, M.
    Passera, R.
    Falco, M.
    Dall'Armellina, S.
    Gontero, P.
    Deandreis, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S520 - S520
  • [32] Impact of 68Ga-PSMA-11 PET staging on clinical decision-making in patients with intermediate or high-risk prostate cancer
    Ferraro, Daniela A.
    Schueler, Helena I. Garcia
    Muehlematter, Urs J.
    Eberli, Daniel
    Mueller, Julian
    Muller, Alexander
    Gablinger, Roger
    Kranzbuehler, Helmut
    Omlin, Aurelius
    Kaufmann, Philipp A.
    Hermanns, Thomas
    Burger, Irene A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (03) : 652 - 664
  • [33] Neoadjuvant lutetium PSMA, the TIME and immune response in high-risk localized prostate cancer
    Eapen, Renu S.
    Williams, Scott G.
    Macdonald, Sean
    Keam, Simon P.
    Lawrentschuk, Nathan
    Au, Lewis
    Hofman, Michael S.
    Murphy, Declan G.
    Neeson, Paul J.
    NATURE REVIEWS UROLOGY, 2024, 21 (11) : 676 - 686
  • [34] PSMA PET FINDINGS IN PATIENTS WITH HIGH-RISK BIOCHEMICAL RECURRENCE AFTER LOCAL TREATMENT OF PROSTATE CANCER
    Handa, Nicole
    Bennett, Richard
    Li, Eric V.
    Ho, Austin
    Huang, Mitchell M.
    Kumar, Sai
    Neill, Clayton
    Patel, Hiten D.
    Schaeffer, Edward M.
    Ross, Ashley E.
    JOURNAL OF UROLOGY, 2024, 211 (05): : E970 - E970
  • [35] 68Ga-PSMA PET/CT for Primary Staging of High-Risk Prostate Cancer: A High-Volume Center Study
    Klingenberg, S.
    Jochumsen, M. R.
    Ulhoi, B. P.
    Fredsoe, J.
    Sorensen, D.
    Borre, M.
    Bouchelouche, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S459 - S460
  • [36] High-risk Prostate Cancer Patients Are Not All Alike
    Troyer, Dean
    EUROPEAN UROLOGY, 2020, 78 (03) : 333 - 334
  • [37] PET-CT Improved High-risk Prostate Cancer Staging in Trial
    Abbasi, Jennifer
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (18): : 1764 - 1764
  • [38] PRIMARY METASTASIS STAGING USING 18F-PSMA-1007 PET-CT IN HIGH-RISK PROSTATE CANCER
    Anttinen, Mikael
    Ettala, Otto
    Malaspina, Simona
    Jambor, Ivan
    Sandell, Minna
    Kajander, Sami
    Rinta-Kiikka, Irina
    Schildt, Jukka
    Saukko, Ekaterina
    Rautio, Pentti
    Timonen, Kirsi L.
    Noponen, Tommi
    Saunavaara, Jani
    Loyttyniemi, Eliisa
    Taimen, Pekka
    Kemppainen, Jukka
    Dean, Peter B.
    Blanco, Roberto Sequeiros
    Aronen, Hannu J.
    Seppanen, Marko
    Bostrom, Peter J.
    JOURNAL OF UROLOGY, 2020, 203 : E952 - E952
  • [39] PSMA/PET-CT in the initial staging of prostate cancer: association between imaging findings and high-risk disease criteria
    Prospero, I.
    Barbosa, D.
    Ferro, J. Castro
    de Castro, S. Fontao
    Teixeira, J.
    Duarte, H.
    Ferreira, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S485 - S485
  • [40] PSMA PET-CT outperforms conventional imaging in high-risk prostate cancer
    Thoma, Clemens
    NATURE REVIEWS UROLOGY, 2020, 17 (06) : 319 - 319
12345